| Dr Nanette Laurie Alexander-thomas, MD | |
|
1235 Linden Blvd, Brooklyn, NY 11212-2438 | |
| (718) 240-5071 | |
| Not Available |
| Full Name | Dr Nanette Laurie Alexander-thomas |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 1235 Linden Blvd, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760483655 | NPI | - | NPPES |
| 01118354 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 173779 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brookdale Hospital Medical Center | Brooklyn, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brookdale Hospital Medical Center | 4284545799 | 279 |
News Archive
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.
› Verified 7 days ago
| Entity Name | Brookdale Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720028772 PECOS PAC ID: 4284545799 Enrollment ID: O20031120000600 |
News Archive
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.
› Verified 7 days ago
| Entity Name | Brookdale Family Care Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962459644 PECOS PAC ID: 7315833159 Enrollment ID: O20040226001107 |
News Archive
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.
› Verified 7 days ago
| Entity Name | Urban Strategies Brookdale Family Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215984422 PECOS PAC ID: 7113818196 Enrollment ID: O20040320000658 |
News Archive
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nanette Laurie Alexander-thomas, MD 1 Brookdale Plz Ste 200, Brooklyn, NY 11212-3198 Ph: (718) 240-7143 | Dr Nanette Laurie Alexander-thomas, MD 1235 Linden Blvd, Brooklyn, NY 11212-2438 Ph: (718) 240-5071 |
News Archive
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.
CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.
Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.
› Verified 7 days ago
Dr. Alexander Usorov, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |